Bitcoin Advocates Seek to Navigate ETF Maze

A new application to list a bitcoin ETF has reignited the debate over these products, but traders say the solution is far from easy.

In late June, VanEck, which has 57 US-listed exchange-traded funds (ETFs), applied for the third time to list a bitcoin ETF, its previous two proposals having been shot down by the US Securities and Exchange Commission (SEC). For this iteration, the money manager is partnering with SolidX and the product—the VanEck SolidX Bitcoin Trust, under the ticker XBTC—would trade on Cboe’s BZE exchange.

The company is hoping to succeed where several others have failed by targeting the offering to

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

CME: CFTC OKs clearing move to Google Cloud

The CFTC has given the Chicago-based exchange approval to run its clearing and settlement infrastructure on the Google Cloud Platform, while the exchange and vendor have extended their partnership to last until at least 2037.

Cutting through the hype surrounding the FDTA rulemaking process

A bill requiring US regulators and institutions to adopt a machine-readable data framework for reporting purposes applies to entity identifiers, but not security identifiers, in a crucial difference, writes Scott Preiss, SVP and global head of Cusip Global Services.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here